These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 8514099

  • 1. [Developments in the therapy of advanced FIGO III ovarian cancer].
    Kuhn W, Jänicke F, Pache L, Hölscher M, Schattenmann G, Schmalfeldt B, Anderl H, Schüle G, Dettmar P, Siewert JR.
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):293-302. PubMed ID: 8514099
    [Abstract] [Full Text] [Related]

  • 2. Urokinase (uPA) and PAI-1 predict survival in advanced ovarian cancer patients (FIGO III) after radical surgery and platinum-based chemotherapy.
    Kuhn W, Pache L, Schmalfeldt B, Dettmar P, Schmitt M, Jänicke F, Graeff H.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):401-9. PubMed ID: 7835780
    [Abstract] [Full Text] [Related]

  • 3. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I, Saip P, Eralp Y, Selam M, Topuz S, Ozluk Y, Aydin Y, Topuz E.
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [Abstract] [Full Text] [Related]

  • 4. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.
    Pectasides D, Fountzilas G, Aravantinos G, Kalofonos C, Efstathiou H, Farmakis D, Skarlos D, Pavlidis N, Economopoulos T, Dimopoulos MA.
    Gynecol Oncol; 2006 Aug; 102(2):285-91. PubMed ID: 16516283
    [Abstract] [Full Text] [Related]

  • 5. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA.
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapy outcome in stage III (FIGO) ovarian carcinomas at the Leipzig University Gynecologic Clinic 1976-1982 and 1985-1991].
    Köhler U, Adam C, Kühndel K.
    Zentralbl Gynakol; 1998 Nov; 120(3):113-20. PubMed ID: 9556901
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer.
    Pickel H, Lahousen M, Petru E, Stettner H, Hackl A, Kapp K, Winter R.
    Gynecol Oncol; 1999 Feb; 72(2):215-9. PubMed ID: 10021304
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic factors of ovarian cancer].
    Ochiai K.
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
    [Abstract] [Full Text] [Related]

  • 11. Stage IVB endometrial cancer: does applying an ovarian cancer treatment paradigm result in similar outcomes? A case-control analysis.
    Landrum LM, Moore KN, Myers TK, Lanneau GS, McMeekin DS, Walker JL, Gold MA.
    Gynecol Oncol; 2009 Feb; 112(2):337-41. PubMed ID: 19041126
    [Abstract] [Full Text] [Related]

  • 12. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P.
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [Abstract] [Full Text] [Related]

  • 13. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
    Wadler S, Yeap B, Vogl S, Carbone P.
    Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766
    [Abstract] [Full Text] [Related]

  • 14. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT, Calaminus G, Wessalowski R, Pathmanathan R, Harms D, Göbel U.
    Klin Padiatr; 2002 Feb 15; 214(4):173-8. PubMed ID: 12165898
    [Abstract] [Full Text] [Related]

  • 15. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.
    Gynecol Oncol; 2005 Mar 15; 96(3):651-7. PubMed ID: 15721407
    [Abstract] [Full Text] [Related]

  • 16. [The surgical treatment of ovarian cancer].
    Burghardt E, Lahousen M, Stettner H.
    Geburtshilfe Frauenheilkd; 1990 Sep 15; 50(9):670-7. PubMed ID: 2272432
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer].
    Sevelda P, Kurz C, Obermair A, Vavra N, Breitenecker G, Czerwenka K, Dittrich C, Salzer H.
    Wien Klin Wochenschr; 1993 Sep 15; 105(24):732-6. PubMed ID: 8116312
    [Abstract] [Full Text] [Related]

  • 20. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D, Touboul E, Lefranc JP, Genestie C, Moureau-Zabotto L, Blondon J.
    Cancer Radiother; 2004 Jun 15; 8(3):155-67. PubMed ID: 15217583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.